Our current groups include: Africa, Middle East, Central Asia (AMECA), Black Employees at Lilly (BE@Lilly), Chinese Culture Network (CCN), EnAble, Evolve, Lilly Indian Network (LIN), Organization of Latinx at Lilly (OLA), Pride (LGBTQ+ Allies), Veterans Leadership Network (VLN) and Women's Initiative for Leading at Lilly (WILL). Develop and apply cheminformatics, statistical, and AI/ML methods that improve hit identification and hit-to-lead across screening technologies, e.g., DNA-encoded library (DEL), high-throughput screening (HTS), virtual screening (VS), fragment-, and affinity-based approaches, and across modalities, e.g., small molecule, macrocyclic peptide, and molecular glues.